COVID-19 Spike Antigen |
|||
30-2018 | Fitzgerald | 1 mg | EUR 400 |
Description: COVID-19 Spike recombinant antigen |
Human IgG antibody Laboratories manufactures the trimeric spike antigen reagents distributed by Genprice. The Trimeric Spike Antigen reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Antigen. Other Trimeric products are available in stock. Specificity: Trimeric Category: Spike Group: Antigen
True Blue |
||
TargetMol Chemicals | 1mg | Ask for price |
Description: True Blue |
True Blue |
||
TargetMol Chemicals | 50mg | Ask for price |
Description: True Blue |
True Blue |
||
TargetMol Chemicals | 5mg | Ask for price |
Description: True Blue |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Human,-Human-IgG1.Affinity:(mol)4.15*10-10(Fortebio),-1.07-nM(ELISA).-FACs-Blocking:-0.892-nM- | EUR 416.5 |
Description: Human, Human IgG1.Affinity: (mol) 4.15*10-10 (Fortebio), 1.07 nM (ELISA) . FACs Blocking: 0.892 nM |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Human,-Human-IgG1.Affinity:(mol)6.99*10-10(Fortebio),0.38-nM(ELISA).-FACs-Blocking:-0.803-nM- | EUR 416.5 |
Description: Human, Human IgG1.Affinity: (mol) 6.99*10-10 (Fortebio) , 0.38 nM (ELISA) . FACs Blocking: 0.803 nM |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Human,-Human-IgG1.-Affinity:(mol)3.1*10-10(Fortebio)0.3-nM(ELISA).-FACs-Blocking:-0.889-nM. | EUR 416.5 |
Description: Human, Human IgG1. Affinity: (mol) 3.1*10-10 (Fortebio) 0.3 nM (ELISA) . FACs Blocking: 0.889 nM. |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Humanized-Monoclonal-Antibody,-human-IgG1.-Affinity:0.561-nM(By-ELISA) | EUR 416.5 |
Description: Humanized Monoclonal Antibody, human IgG1. Affinity:0.561 nM (By ELISA) |
SARS-CoV-2 full-length Trimeric Spike Antigen (South African Variant, 10mg) |
|||
BSV-COV-PR-88 | BioServUK | 10 mg | EUR 15168 |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (South African Variant, 10mg) |
SARS-CoV-2 Spike Glycoprotein (Trimeric), His-Tag (CHO): HRP Conjugate |
|||
REC31871-HRP-100 | The Native Antigen Company | 0.1 | EUR 798.62 |
Description: Trimeric SARS-CoV-2 spike protein in prefusion confirmation, conjugated to horseradish peroxidase (HRP). C-terminal transmembrane region is replaced with a trimerization domain and a polyhistidine tag. Contains two stabilizing proline mutations and scrambled S1/S2 furin cleavage site (Wrapp et al., 2020). |
SARS-CoV-2 Spike Glycoprotein (Trimeric), His-Tag (CHO): HRP Conjugate |
|||
REC31871-HRP-500 | The Native Antigen Company | 0.5 | EUR 2796.44 |
Description: Trimeric SARS-CoV-2 spike protein in prefusion confirmation, conjugated to horseradish peroxidase (HRP). C-terminal transmembrane region is replaced with a trimerization domain and a polyhistidine tag. Contains two stabilizing proline mutations and scrambled S1/S2 furin cleavage site (Wrapp et al., 2020). |
SARS-CoV-2 full-length Trimeric Spike Antigen MultiPack (7 Variants & Wild 1mg each_) |
|||
BSV-COV-PR-MP-1 | BioServUK | 1 mg | EUR 18960 |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen MultiPack (7 Variants & Wild 1mg each_) |
SARS-CoV-2 (B.1.351) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC31963-100 | The Native Antigen Company | 0.1 | EUR 636.6 |
Description: SARS-CoV-2 Spike protein, South African variant of concern. Relative to Wuhan-Hu-1 contains following amino acid changes: L18F, D80A, D215G, del242-244, K417N, E484K, N501Y, D614G, A701V. The protein contains six proline amino acid changes (commonly known as Hexapro) to stabilize it in a trimeric pre-fusion state. The furin cleavage site has been altered to 'SRAS' and deactivated. |
SARS-CoV-2 (B.1.351) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC31963-500 | The Native Antigen Company | 0.5 | EUR 2421.37 |
Description: SARS-CoV-2 Spike protein, South African variant of concern. Relative to Wuhan-Hu-1 contains following amino acid changes: L18F, D80A, D215G, del242-244, K417N, E484K, N501Y, D614G, A701V. The protein contains six proline amino acid changes (commonly known as Hexapro) to stabilize it in a trimeric pre-fusion state. The furin cleavage site has been altered to 'SRAS' and deactivated. |
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC32008-100 | The Native Antigen Company | 0.1 | EUR 636.6 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. |
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC32008-300 | The Native Antigen Company | 0.3 | EUR 565.87 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. |
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC32008-500 | The Native Antigen Company | 0.5 | EUR 2421.37 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. |
SARS-CoV-2 (Omicron BA.4/BA.5) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC32026-100 | The Native Antigen Company | 0.1 | EUR 636.6 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: T19I, del24-26, A27S, del69-70, G139D, E154G, del155-156, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, L452R, T478K, E484Q, F486V, P499R, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. |
SARS-CoV-2 (Omicron BA.4/BA.5) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC32026-500 | The Native Antigen Company | 0.5 | EUR 2421.37 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: T19I, del24-26, A27S, del69-70, G139D, E154G, del155-156, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, L452R, T478K, E484Q, F486V, P499R, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. |
SARS-CoV-2 (B.1.351) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC31963-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: SARS-CoV-2 Spike protein, South African variant of concern. Relative to Wuhan-Hu-1 contains following amino acid changes: L18F, D80A, D215G, del242-244, K417N, E484K, N501Y, D614G, A701V. The protein contains six proline amino acid changes (commonly known as Hexapro) to stabilize it in a trimeric pre-fusion state. The furin cleavage site has been altered to 'SRAS' and deactivated. Protein is conjugated to biotin. |
SARS-CoV-2 (C.37) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC31976-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: SARS-CoV-2 Spike protein containing following amino acid changes: G75V, T76I, 246-252del, D253N, L452Q, F490S, D614G, Q675H, T859N. The protein is stabilized as a pre-fusion trimer due to six amino acid changes in the S2 portion of Spike (HexaPro). The furin cleavage site has been mutated to GSAS. Protein is conjugated to biotin. |
SARS-CoV-2 (B.1.617.2; AY.1, AY.2, AY.3) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC31975-100 | The Native Antigen Company | 0.1 | EUR 636.6 |
Description: SARS-CoV-2 Spike protein containing following amino acid changes: T19R, T95I, G142D, E156G, del157-158, W258L, N417K, L452R, T478K, D614G, P681R, D950N. The protein is stabilized as a pre-fusion trimer due to six amino acid changes in the S2 portion of Spike (HexaPro). The furin cleavage site has been mutated to GSAS. |
SARS-CoV-2 (B.1.617.2; AY.1, AY.2, AY.3) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC31975-500 | The Native Antigen Company | 0.5 | EUR 2421.37 |
Description: SARS-CoV-2 Spike protein containing following amino acid changes: T19R, T95I, G142D, E156G, del157-158, W258L, N417K, L452R, T478K, D614G, P681R, D950N. The protein is stabilized as a pre-fusion trimer due to six amino acid changes in the S2 portion of Spike (HexaPro). The furin cleavage site has been mutated to GSAS. |
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC32008-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. Protein is biotinylated. |
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC32008-Biotin-500 | The Native Antigen Company | 0.5 | EUR 3268.47 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. Protein is biotinylated. |